In this episode, Sandra Wong, MD, speaks with Ronald DeMatteo, MD, about the SSO Research and Education Fund’s “Honor Your Mentor” campaign. Dr. DeMatteo talks about his mentors, Leslie Blumgart, MD, and Murray Brennan, MD.

Vadim Gushchin, MD, Brian Badgwell, MD, and Jeremy Davis, MD discuss the role and timing of preoperative treatments before cytoreduction and HIPEC for gastric cancer. The panelists offer useful tips on surgical management of gastric cancer patients with peritoneal carcinomatoses, such as how to decide on the extent of the surgery, whether patients with CDH1 mutation should be treated differently, and others.

In this episode of SurgOnc Today™, Brian Badgwell, MD, Farshid Dayyani MD, PhD, and Maheswari Senthil, MD, discuss the management of gastric cancer peritoneal carcinomatosis. Evaluation of response to systemic treatment, use of intraperitoneal chemotherapy and nuances of patient selection for Cytoreductive surgery are discussed.

In this episode, SSO President James Howe, MD, SSO Secretary Kelly Hunt, MD, and Matthew Katz, MD, discuss ACS Commission on Cancer accreditation standards 5.3 through 5.8, what these standards are, where they came from, and why they are so important to all surgeons and their patients.

In this episode of SurgOnc Today™, Benjamin Golas, MD, Mio Kitano, MD and Laleh Melstrom, MD, from the SSO Gastrointestinal Disease Site Work Group provide an overview of the current data regarding the multimodal approach to the diagnosis and management of Gastrointestinal Stromal Tumors.  

In this episode of SurgOnc Today™, Gastrointestinal Disease Site Work Group Chair, Vance Sohn, MD, discusses PRRT with SSO President, James Howe, MD and Thomas Clancy, MD from the Gastrointestinal Disease Site Work Group. They discuss the current indications, efficacy, and what the future holds for PRRT.

In this episode, Melissa Hogg, MD, Chair of the Hepato-Pancreato-Biliary Disease Site Work Group and disease site work group members Jin He, MD, PhD, and H.J. Kim, MD, discuss the common and mostly benign imaging findings of the liver and biliary system with a focus on indications for surveillance, surgery, or additional necessary work-up.

The recently published EORTC 62092 trial (STRASS) examines abdominal recurrence in patients after surgical resection of retroperitoneal sarcomas.  This randomized study compared these recurrences in patients receiving neoadjuvant radiation versus those undergoing surgery alone.  Rebecca Gladdy MD, PhD and Ashleigh Guadagnolo, MD join moderator and SSO Sarcoma Disease Site Work Group Chair, Aimee Crago, MD, PhD, to provide insight and analysis from both surgical and radiation oncology perspectives, discussing how this practice-changing trial is altering the approach to patients with these diseases. 

Alexander Parikh, MD, MPH, Vice Chair of the SSO Hepato-Pancreato-Biliary Disease Site Work Group moderates as Marcus Tan, MD, presents practice changing studies from 2019.

Kandace McGuire, MD, Chair of the SSO Breast Disease Site Work Group, moderates as Breast DSWG member Jennifer Plichta, MD, MS, presents practice changing studies from 2019.